Literature DB >> 7560959

Infection control programmes--are they cost-effective?

S Mehtar1.   

Abstract

Infection control (IC) programmes are cost-effective in the long-term but much depends on the available resources and the support from management. The funding of IC programmes at present is linked to the Microbiology Department and a separate budget needs to be established. The best use of resources is to apply a risk assessment to each situation which presents and to adapt protocols accordingly. For example, the treatment of a carrier or an infected patient with methicillin-resistant Staphylococcus aureus cost 374 pounds and 2454 pounds, respectively in 1993, the major portion of the cost being due to an increased length of stay which was two days and 10 days, respectively. It is more cost-effective to treat carriers. The other cost-effective investment is in education and reinforcement of simple messages. Formal lectures seem to be the least effective way of producing long-term effect; frequent ward visits or contacts are most effective. Also, there is better compliance when there is a perceived risk to the staff themselves. The availability of the IC team to advise helps reduce waste and therefore cost. This is particularly true of antibiotic usage where it was noted that without guidance, the antibiotic usage increased by 2000 pounds per month when compared to a similar period in the previous year. The available provisions for IC programmes in the UK are utilized exceptionally well when compared with other countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560959     DOI: 10.1016/0195-6701(95)90003-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  1 in total

1.  Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.

Authors:  D J Austin; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.